Skip to main content

TimesSquare Capital Management, LLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1313816 NEW YORK, NY

Position in XENE

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$20,892,887
-$2,984,519 QoQ
Shares Held
359,293
-32.6% QoQ
Ownership
0.372%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 92.17908503644658.ToString("F0")% Shared 0.ToString("F0")% None 7.820914963553423.ToString("F0")%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TimesSquare Capital Management, LLC holds $398,607,399 across 16 Biotechnology names. XENE ranks #7 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 XENE
Xenon Pharmaceuticals Inc.
This page
359,293 $20,892,887

All Filings in XENE

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,892,887 359,293
2025-12-31 $23,877,406 532,740
2025-09-30 $22,355,520 556,800
2025-06-30 $17,879,874 571,242
2025-03-31 $25,013,236 745,551
2024-12-31 $33,274,920 848,850
2024-09-30 $30,641,395 778,293
2024-06-30 $29,417,682 754,493
2024-03-31 $31,735,297 737,173
2023-12-31 $36,569,521 793,954
2023-09-30 $20,174,042 590,575
2023-06-30 $16,436,612 426,925
2023-03-31 $14,594,983 407,795
2022-12-31 $19,012,357 482,180